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Background. The optimal time to initiate hands-on training in endoscopic ultrasound fine needle aspiration (EUS-FNA) is unclear.
We studied the feasibility of initiating EUS-FNA training concurrent with EUS training. Methods. Three supervised trainees were
instructed on EUS-FNA technique and allowed hands-on exposure from the onset of training. The trainee and attending each
performed passes in no particular order. During trainee FNA, the attending provided verbal instruction as needed but no hands-
on assistance. A blinded cytopathologist assessed the adequacy (cellularity) and diagnostic yield of individual passes. Primary
outcomes compared cellularity and diagnostic yield of attending versus fellow FNA passes. Results. We analyzed 305 FNA sites,
including pancreas (51.2%), mediastinal/upper abdominal lymph node (LN) (28.5%) and others (20.3%). The average proportion
of fellow passes with AC was similar to attending FNA—pancreas: 70.3 versus 68.8%; LN: 79.0 versus 81.7%; others 65.5 versus
68.7%; P > 0.05); these did not change significantly during the training period. Among cases with confirmedmalignancy (n = 179),
the sensitivity of EUS-FNA was 78.8% (68.4% fellow-only versus 69.6% attending only). There were no EUS-FNA complications.
Conclusions. When initiated at the onset of EUS training, attending-supervised, trainee-directed FNA is safe and has comparable
performance characteristics to attending FNA.
1. Introduction
Expertise in endoscopic ultrasound (EUS) requires the
development of both cognitive and technical proficiency.
The American Society of Gastrointestinal Endoscopy (ASGE)
recommends a minimum of 150 total supervised procedures,
75 of which have a pancreatobiliary indication, and 50 cases
of fine needle aspiration (FNA) (25 of which are pancreatic
FNA) before competency can be determined [1]. These
guidelines are based on limited studies of the learning curve
in EUS imaging [2–4].
FNA represents a common diagnostic maneuver during
EUS. Although it is a relatively safe intervention [5], the
diagnostic accuracy of FNA in nontrainees improves with
greater experience [6, 7]. Mertz and Gautam demonstrated
a consistent improvement in the sensitivity of EUS-FNA
of pancreatic lesions through 30–40 FNA cases for a single
endoscopist who did not undergo dedicated training in
EUS [7]. Eloubeidi and Tamhane tracked the diagnostic
accuracy and safety of FNA in a single endoscopist who
had performed >300 EUS during a dedicated fourth year
training program [6]. During the first 300 FNAs performed
after training, the diagnostic accuracy did not improve over
time, but fewer passes per lesion were required, suggesting
continued learning after a high volume training experience.
A society position statement argues that “successful and
safe FNA requires competence in standard EUS imaging” [8]
despite no data from advanced endoscopy fellowships in
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the US evaluating the optimal time to commence hands-on
training in EUS-FNA. By incorporating the technical aspects
of hands-on training in EUS-FNA early in the cognitive
training period, fellows may develop competency in this
particular skill set earlier in their development. Therefore,
we sought to describe the safety and diagnostic yield
of attending-supervised EUS-FNA performed by advanced
endoscopy fellows at the onset of their training.
2. Methods
2.1. Overview. Each year, the Division of Gastroenterology at
Washington University in St. Louis trains 1-2 individuals in
advanced endoscopic procedures; these advanced fellows had
already completed a traditional three-year gastroenterology
fellowship but had no prior formal training in EUS. Our
practice is to introduce both cognitive and technical aspects
of EUS training from the start of the fellowship. Specif-
ically, fellows are instructed on EUS-FNA technique and
begin hands-on exposure to this maneuver (i.e., the fellow
performs FNA) at the beginning of training, in order to
maximize their hands-on training in EUS-FNA during their
advanced fellowship. From July, 2008 through June, 2010, we
prospectively collected data on the safety and accuracy of
attending-supervised EUS-FNA performed by fellows. The
study was approved by the Washington University in St.
Louis Human Research Protection Oﬃce.
2.2. FNA Technique. We prospectively enrolled EUS proce-
dures involving FNA that were performed by an attending
physician along with a fellow in a combined EUS/cytology
database during the study period. We excluded those cases
that did not include FNA or those in which the attending
performed the entire procedure. In addition, FNA of cystic
lesions was excluded, since most of these procedures involve
one needle pass. During all cases of EUS-FNA, fellows and
their supervising attending were each asked to perform an
equal or near-equal number of passes but in no particular
order.
At our institution, cytotechnologists attend EUS-FNA
cases and prepare slides, which they then transport to an
attending cytopathologist. Therefore, without a preliminary
assessment on site, our standard practice is to perform 6-7
passes from solid lesions and 3-4 passes from lymph nodes
[9]. However, the total number of passes per lesion is left
to the discretion of the attending. All FNA procedures were
performed using a curvilinear array echoendoscope (GF-
UC140P, Olympus America, Center Valley, Pa, USA). The
lesion of interest could have been identified by the fellowwith
or without attending assistance or by the attending alone.
During fellow-directed FNA, the supervising attending may
have assisted with positioning of the endoscope, but the
FNA was entirely performed by the fellow. The degree of
attending assistance in identifying the lesion and positioning
the echoendoscope for FNA was not recorded, but in all
cases of fellow-directed FNA, the trainee inserted the FNA
needle into the lesion and completed the process of tissue
acquisition for that pass without any hands-on assistance
from the supervising attending. FNA was performed using
a 22 or 25 gauge needle (EchoTip Ultra, Cook Medical,
Bloomington, Inn, USA). For all passes (fellow or attending
directed), the use of suction and a stylet was left to the
discretion of the attending endosonographer [10].
2.3. Protocol. Fellows recorded which passes they performed
(passes were numbered consecutively). Each pass was
reviewed by a cytopathologist to assess for (1) adequacy,
classified as yes or no and (2) diagnosis (classified as
negative, atypical, suspicious, or positive for malignancy).
The cytopathologist was blinded to which passes were made
by the attending and which by the fellow. Per standard
practice in our endoscopy unit, all patients were contacted
via telephone 3-4 days after EUS to assess for delayed com-
plications; if the patient could not be reached by telephone,
then a postcard was mailed with contact information.
2.4. Objectives. Our primary objectives were twofold: (1)
to evaluate complication rates of FNA when performed by
a supervised fellow and (2) to compare the performance
characteristics of EUS-FNA between the attendings and
fellows. The first performance characteristic is specimen
adequacy, determined by a blinded cytopathologist. The
second characteristic is the proportion of cases where at least
one pass would have confirmed a diagnosis of malignancy;
this outcome was limited to those cases where malignancy
was confirmed either by cytology or a minimum of six
months of followup after the EUS. We sought to compare
the frequency of achieving at least one diagnostic specimen
between groups. A diagnostic specimen was defined as a
definitive cytologic diagnosis of malignancy. Using this crite-
rion for diagnosis, we also compare the per-site sensitivity of
supervised fellow-FNA compared to attending FNA. Finally,
we report the learning curve for each fellow, defined as the
average proportion of adequate specimens per FNA site over
the course of their training period (one year).
2.5. Statistical Analysis. We classified each EUS-FNA site as a
separate event for the purpose of this analysis. For each FNA
site, passes were grouped by the performing endoscopist:
fellow or attending. We report overall complication rates for
FNA as simple proportions. For each FNA site, we calculated
a percent specimen adequacy for the fellow and attending by
dividing the number of adequate FNA passes by the total
number of FNA passes performed by that individual. We
then compare the average proportion of adequate specimens
(a.k.a., specimen adequacy) between groups using one-
way analysis of variance (ANOVA). Dichotomous variables
(e.g., proportions) were compared using Chi square tests.
Statistical analyses were performed using Stata v. 11.0
(StataCorp LP, College Station, Tex, USA).
3. Results
During the study period, 2,688 EUS procedures were per-
formed; 38 EUS-FNA sites were excluded due to missing data
adjudicating fellow versus attending passes. Of the remaining
cases, 305 (11%) EUS-FNA sites met our study criteria, with
EUS-FNA being performed by both an attending and a fellow
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Table 1: Procedure characteristics.
Variable
Fellow A Fellow B Fellow C
Total number of cases P value
(n = 112) (n = 99) (n = 94)
Location (%)
(i) Pancreas 59 (52.7) 54 (54.6) 43 (45.7) 156 (51.2)
0.55†(ii)Mediastinal/upper abdominal lymph node 29 (25.9) 25 (25.2) 33 (35.1) 87 (28.5)
(iii) All others 24 (21.4) 20 (20.2) 18 (19.2) 62 (20.3)
Fellow FNA passes/site (mean± SD) 3.2± 1.1 2.8± 1.2 3.0± 1.1 N/A 0.873‡
Attending FNA passes/site (mean± SD) 2.7± 1.2 3.3± 1.4 2.8± 1.5 N/A 0.02‡
†Pearson’s test of independence.
‡One-way analysis of variance.
Table 2: Performance characteristics of supervised fellow-FNA and attending-FNA.
Variable Fellow∗ Attending∗∗ P value
Average proportion of FNA passes with adequate cellularity (±SD)
(i) Pancreas 70.3± 32.4 68.8± 35.6 0.71
(ii) Mediastinal/upper abdominal lymph node 79.0± 34.1 81.7± 33.7 0.61
(iii) All others 65.5± 37.5 68.7± 38.8 0.65
Proportion of cases with at least one diagnostic specimen (95%
confidence interval) (n = 179 cases)
(i) Pancreas 70.2 (61.0, 79.4) 71.2 (62.1, 80.4) 0.87
(ii) Mediastinal/upper abdominal lymph node 57.8 (43.4, 72.2) 62.2 (48.1, 76.4) 0.67
(iii) All others 78.1 (63.8, 92.4) 75.0 (60.0, 90.0) 0.77
Variables are expressed as the average proportion± SD, per site.
∗Fellow denotes the cumulative data from all three participating EUS fellows.
∗∗Attending FNA v. all fellow FNA.
and a cytopathologist study worksheet being completed.
There were no complications associated with EUS-FNA. The
indications for EUS-FNA and mean number of passes per
site performed by the fellow and attending are summarized
in Table 1. The majority of sites were pancreatic lesions
(51.2%) and mediastinal or upper abdominal lymph nodes
(28.5%). The average number of FNA passes per case by both
attending and trainee were 6.3 ± 1.5 (pancreas), 5.2 ± 1.9
(lymph node) and 5.9±1.4 (all others) (P = 0.007). All three
fellows performed a similar number of passes/site.
The proportion of passes that yielded adequate cellular-
ity according to cytopathologist interpretation was similar
between fellows and attendings, irrespective of the FNA site
(Table 2). Specifically, 66%–79% of fellow FNA passes had
adequate cellularity as compared to 69%–82% of attending
FNA passes (P > 0.05 for each site: pancreas, lymph node,
other). A malignant diagnosis was ultimately confirmed in
179 (58.3%) cases. In this subgroup having a confirmation
of malignancy, the proportion of cases where the fellow
achieved at least one diagnostic FNA pass was similar
to the attending, irrespective of location (Table 2). When
considering all cases of “suspicious” or “highly suspicious”
for malignancy as negative, the overall sensitivity of EUS-
FNA was 78.8% in this series; using fellow-FNA passes alone,
the sensitivity would have been 68.4% as compared to 69.6%
for attending-FNA passes (P = 0.82).
The proportion of fellow EUS-FNA passes with adequate
cellularity did not significantly change throughout the train-
P = 0.52 P = 0.06
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Figure 1: Change in the average proportion of adequate specimens
during the training year.
ing period (Figure 1). During the first quarter of the training
period, 70.5% of fellow passes yielded adequate tissue for
analysis as compared to 73.2% during the fourth (P = 0.52,
test of independence).
4. Discussion
We present findings from the first prospective study of
attending supervised EUS-FNA by advanced endoscopy
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fellows. Our study demonstrates that fellow-directed EUS-
FNA can be performed safely and eﬀectively from the onset
of training in diagnostic EUS.
Based on limited data and expert opinion, the ASGE rec-
ommends 150 supervised cases, 75 of which involve pancre-
atobiliary indications and 50 with EUS-FNA before a formal
assessment of competency can be performed [1]. There are
no definitive recommendations mandating a fourth year of
training in EUS although a survey of GI fellowship directors
suggests many 3-year and advanced fellows complete their
training with fewer procedures than currently suggested
[11, 12]. A survey of 191 endosonographers at a conference
on EUS reported a highly variable training experience
ranging from self-instruction to observation to hands-on
training [13]. Based on limited retrospective data, physicians
who have undergone advanced training in pancreatobiliary
EUS appear to have greater proficiency with EUS-FNA at
the onset of training compared to those who have not
[14].
Studies investigating the learning curve of EUS-FNA
are limited to the experiences of junior faculty who have
completed limited [7] or more extensive hands-on training
in EUS [6]. Both of these studies demonstrate increased
proficiency with greater volume, even in the case of Eloubeidi
et al., where the subject/endosonographer had completed
316 supervised EUS procedures, 82 of which involved EUS-
FNA during his training period.
Under attending supervision, the accuracy of fellow EUS-
FNA, defined as specimen adequacy, achieving at least one
diagnostic sample, and sensitivity, is comparable to attending
FNA and does not change during the training period. We
assume that the amount of attending guidance during fellow
FNA diminishes as the competency of the fellow steadily
improves; our study was not designed to quantify this. Our
results describe the technical component of EUS-FNA; that
is, the fellow can follow instruction from their supervisor
and complete the hands-on aspects of FNA at the onset of
training. Our study was not designed to comment on the
progression of the cognitive aspects of EUS and EUS-FNA
during the training period. Since the degree of attending
intervention during each FNA was not recorded, we cannot
determine if or when the trainee was able to independently
perform EUS-FNA.
Fellows are not capable of independently performing
EUS-FNA from the start; rather, our results show that
the presence of attending supervision assures comparable
adequacy when the fellow performs FNA versus attending-
directed FNA. Therefore, allowing fellow-directed FNA ear-
lier in the training period maximizes the number of super-
vised cases without compromising patient safety and the
performance characteristics (sensitivity/specificity) of EUS-
FNA. By considering all “suspicious” samples as negative,
our reported sensitivity of EUS-FNA (78.8%) is consistent
with previous studies [15–18]. The optimal approach to
training in EUS remains unclear, but our findings suggest
early hands-on exposure to EUS-FNA is safe and does not
reduce the sensitivity of FNA for confirming a diagnosis
of malignancy. Animal models and endoscopic simulators
may further shorten the learning curve for trainees by
providing early hands-on experience, combining advances in
the technical and cognitive aspects of EUS [19–22].
5. Conclusions
Attending-supervised, fellow-directed EUS-FNA from the
onset of training in EUS is safe and feasible. By allowing
early hands-on exposure to EUS-FNA, the fellow maximizes
their experience with this technique before embarking on an
independent career as an endosonographer. In addition to
studying other technical and cognitive benchmarks in EUS,
future studies should focus on the learning curve of achieving
independent EUS-FNA.
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